Printer Friendly

Pandemic and Avian Influenza Vaccine Industry Global and Chinese Market Research Reports.

DALLAS, January 21, 2015 /PRNewswire/ -- adds Global and Chinese Pandemic Influenza Vaccine Industry, 2009-2019 Market Research Report and Research Report on China Avian Influenza Vaccine Industry, 2014-2018 to its store.

This is a professional and in-depth study on the current state of the global Pandemic Influenza Vaccine industry with a focus on the Chinese market. The report provides key statistics on the market status of the Pandemic Influenza Vaccine manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

Firstly, the report provides a basic overview of the industry including its definition, applications and manufacturing technology. Then, the report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2009-2014 market shares for each company. Through the statistical analysis, the report depicts the global and Chinese total market of Pandemic Influenza Vaccine industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, and by application/type for the competitive landscape analysis. The report then estimates 2014-2019 market development trends of Pandemic Influenza Vaccine industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out. In the end, the report makes some important proposals for a new project of Pandemic Influenza Vaccine Industry before evaluating its feasibility. Overall, the report provides an in-depth insight of 2009-2019 global and Chinese Pandemic Influenza Vaccine industry covering all important parameters.

Comprehensive Table of Contents and more for the report " Global and Chinese Pandemic Influenza Vaccine Industry, 2009-2019 Market Research Report " is available at OR Order a copy of this report at

Many countries choose to kill all infected poultry to control avian influenza, instead of immunizations. The total number of poultry exceeds 10 billion in China. Epidemic diseases, which are difficult to control, will result in huge losses. Therefore, it is quite necessary to immunize the poultry with avian influenza vaccines.

Avian influenza vaccines have been used for more than 10 years in China. Some poultry farms in China began to use H5N1 avian influenza vaccines voluntarily 10 years ago without compulsory requirements. Chinese avian influenza vaccine industry was in the initial stage in 20012005 with upcoming problems. To resolve these problems, the Ministry of Agriculture of China sets up an entry barrier for the avian influenza vaccine production and imposes strict supervision. The Ministry of Agriculture of China established strict regulations on the production and sales of avian influenza vaccines. For instance, avian influenza vaccines must be produced in workshops that are in compliance with GMP and inspected every year.

In China, the subsidy provided by the government over killing the infected poultry is CNY 10 per bird. In case of serious epidemic diseases, the subsidy amount will be higher.

In 2013, the live stock volume of laying hens in China was about 1.4 billion while that of broilers was approximately 10 billion. The output volume of eggs in China was 28.76 million tons in 2013, up by 0.5% YOY. According to National Compulsory Immunization Plan of Animal Epidemic Diseases 2013 issued by Ministry of Agriculture of China, the government conducts compulsory immunizations against 4 diseases, including highly pathogenic avian influenza. The government is responsible for the expenses. In 2013, the market size of avian influenza vaccines exceeded CNY 1 billion in China.

With the increasing living standards of Chinese people, the demand for eggs and poultry meat is growing accordingly, which promotes the development of poultry industry. In China and other neighboring countries, avian influenza, especially highly pathogenic avian influenza, has not been effectively controlled yet. For example, H5N1 highly pathogenic avian influenza broke out in North Korea in May 2013. Besides H5N1, H5 and H7 and other subtype highly pathogenic avian influenza are also highly possible to break out.

Therefore, it is predicted that the market size of avian influenza vaccines will keeping increasing and many animal healthcare enterprises attach attention to this market.

Through this report, the readers can acquire the following information:

* Incidence Status of Avian Influenza

* Status of Poultry Breeding in China

* Policy Environment and Government Procurement for Avian Influenza Vaccines in China

* Supply and demand Status of Avian Influenza Vaccines in China

* Major Manufacturers of Avian Influenza Vaccines and the Operation Status in China

* Prospect of China Avian Influenza Vaccine Industry

The Following Enterprises and People Are Recommended to Purchase This Report:

* Manufacturers and Trading Enterprises of Animal Vaccines

* Poultry Breeding Enterprises

* Management Organizations of Livestock Industry

* Investors and Research Institutes Concerned about the Avian Influenza Vaccine Industry

Comprehensive Table of Contents and more for the report " Research Report on China Avian Influenza Vaccine Industry, 2014-2018" is available at OR Order a copy of this report at

Major Manufacturers of Avian Influenza Vaccines in China, 2012-2013 QYH Biotech Company Limited, Enterprise Profile, Production Status of Avian Influenza Vaccines, Development Strategies of the Enterprise, Qingdao Yebio Bioengineering Co., Ltd., Zhaoqing Dahuanong Animal Health Products Co., Ltd., Liaoning Yikang Biology Co., Ltd., Harbin Weike Biotechnology, Development Company, Harbin Pharmaceutical Group Biological Vaccines Co., Ltd., Guangdong Winsun Pharmaceutical Co., Ltd., Shandong Sinder Technology Co., Ltd. and Merial Nanjing Animal Health Co., Ltd.

About Us: is an online market research reports library of 500,000+ reports and in-depth studies of 5000+ micro markets. We provide reports by 100+ publishers on a range of categories and industries.


Ritesh Tiwari

TX, Dallas North - Dominion Plaza, 17304, Preston Road, Suite 800, Dallas 75252

Tel: +1-888-391-5441

Connect with Us:

G+ / Google Plus:



RSS / Feeds:
COPYRIGHT 2015 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2015 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire Europe
Geographic Code:9CHIN
Date:Jan 20, 2015
Previous Article:RA Holding Corp. Pays Exit Facility in Full and Announces Planned Partial Redemption of Sukuk Certificates.
Next Article:What CEOs Need to Lead in an Uncertain and Hyper-Connected World.

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters